The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine

• Päätekijä: Barbara Melosky (auth)
• Muut tekijät: Vera Hirsh (auth)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Frontiers Media SA 2015
• Sarja: Frontiers Research Topics
• Aiheet: Medicine; Epidermal growth factor receptors; Non small cell lung cancer; Echinoderm microtubule associated protein like 4; Quality of Life; KRAS; Anaplastic lymphoma kinase; personalized medicine
• Linkit: DOAB: download the publication; DOAB: description of the publication

Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic che...